
PRCT
PROCEPT BioRobotics Corporation
$38.46
+$1.07(+2.86%)
27
Overall
--
Value
27
Tech
--
Quality
Market Cap
$2.08B
Volume
666.76K
52W Range
$36.75 - $103.81
Target Price
$65.60
Order:
Income Statement
Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|
REVENUE | ||||||
Total Revenue | $34.5M | $75.0M | $136.2M | $224.5M | ||
Total Revenue | $34.5M | $75.0M | $136.2M | $224.5M | ||
COST OF GOODS SOLD | ||||||
Cost of Revenue | $18.6M | $37.9M | $65.1M | $87.4M | ||
GROSS PROFIT | ||||||
Gross Profit | $15.9M | $37.1M | $71.0M | $137.1M | ||
OPERATING EXPENSES | ||||||
Operating Expenses | $70.0M | $117.8M | $180.2M | $233.7M | ||
Research & Development | $19.0M | $29.0M | $48.4M | $62.3M | ||
Research Expense | $19.0M | $29.0M | $48.4M | $62.3M | ||
Selling, General & Administrative | $69.6M | $88.8M | $131.8M | $171.4M | ||
Selling & Marketing Expenses | $18.6M | $100.0K | $300.0K | $500.0K | ||
General & Administrative Expenses | $51.0M | $88.8M | $131.8M | $171.4M | ||
Salaries & Wages | -- | $10.3M | $19.1M | $31.8M | ||
Amortization | $300.0K | $300.0K | $300.0K | $300.0K | ||
Other Operating Expenses | $-510.0K | $-783.0K | $-842.0K | $-1.3M | ||
OPERATING INCOME | ||||||
Operating income | $-54.2M | $-80.7M | $-109.2M | $-96.6M | ||
EBITDA | $-50.8M | $-82.0M | $-102.1M | $-86.2M | ||
NON-OPERATING ITEMS | ||||||
Interest Expense (Non-Operating) | $5.8M | $5.2M | $4.0M | -- | ||
Intinc | $76.0K | $2.5M | $7.6M | $10.9M | ||
Net Non-Operating Interest Income/Expense | $-5.8M | $2.7M | $7.6M | $10.9M | ||
Gain on Sale of Securities | $135.0K | $-283.0K | $-107.0K | $-114.0K | ||
Other Income/Expense | $-199.0K | $-3.7M | $107.0K | $-726.0K | ||
Other Special Charges | $64.0K | $-3.3M | -- | -- | ||
PRE-TAX INCOME | ||||||
EBIT | $-54.2M | $-82.0M | $-105.9M | $-91.4M | ||
Pre-Tax Income | $-60.0M | $-87.2M | $-109.2M | $-91.4M | ||
NET INCOME | ||||||
Net Income | $-59.9M | $-87.2M | $-105.9M | $-91.4M | ||
Net Income (Continuing Operations) | $-59.9M | $-87.2M | $-105.9M | $-91.4M | ||
Net Income (Discontinued Operations) | $-59.9M | $-87.2M | $-105.9M | $-91.4M | ||
Net Income (Common Stockholders) | $-59.9M | $-87.2M | $-105.9M | $-91.4M | ||
Normalized Income | -- | -- | -- | $-96.5M | ||
TOTALS | ||||||
Total Expenses | $88.6M | $155.7M | $245.4M | $321.1M | ||
SHARE & EPS DATA | ||||||
Average Shares Outstanding | $16.5M | $44.4M | $47.3M | $52.1M | ||
Average Shares Outstanding (Diluted) | $16.5M | $44.4M | $47.3M | $52.1M | ||
Shares Outstanding | $44.0M | $44.9M | $51.0M | $54.8M | ||
Basic EPS | $-3.63 | $-1.96 | $-2.24 | $-1.75 | ||
Basic EPS (Continuing Operations) | $-3.63 | $-1.96 | $-2.24 | $-1.75 | ||
Diluted EPS | $-3.63 | $-1.96 | $-2.24 | $-1.75 | ||
Diluted EPS (Continuing Operations) | $-3.63 | $-1.96 | $-2.24 | $-1.75 | ||
OTHER METRICS | ||||||
Commission Expenses | $18.6M | -- | -- | -- | ||
Marketing Expense | $18.6M | $100.0K | $300.0K | $500.0K | ||
Net Income From Other Gains Losses | $121.0K | -- | -- | -- | ||
Other Gand A | $51.0M | $88.8M | $131.8M | $171.4M | ||
Other Write Off | -- | -- | -- | $-840.0K |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | PRCT | $38.46 | +2.9% | 666.76K |
3 | ||||
4 | ||||
5 | ||||
6 |
Get PROCEPT BioRobotics Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW